$RTX

RTX Keeps Winning Contracts, but Jim Cramer Sees a Complication

RTX Corporation (NYSE:RTX) reported Q2 sales of $24.7B, up 14%, and adjusted EPS of $1.89, up 21%. Its backlog reached $289B. Management raised its full-year adjusted EPS outlook to $7.10-$7.25. RTX secured a $20.7B missile production contract. Jim Cramer noted defense demand but concerns about commercial aviation and engine-related costs.

Original reporting
Published Oct 9, 2026, 2:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 2:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RTX Keeps Winning Contracts, but Jim Cramer Sees a Complication — source image
Decision brief

The 30-second read

$RTXBullishMed
01

Why it matters

The contract adds to RTX's backlog and improves earnings outlook, but commercial‑aviation headwinds remain.

02

Market read

RTX's large defense award and guidance raise could lift the stock, though commercial‑aviation concerns temper the rally.

03

What to watch

Potential cost overruns on the powder‑metal issue and broader aerospace slowdown may dampen earnings

Relevance 7/10Novelty 7/10Timing: recently after earnings

Background

The article recaps RTX's Q2 results (already public) and focuses on a new $20.7 billion missile contract and raised guidance.

Company-level read

Ticker impact

$RTXBullishMedium confidence
Context

RTX announced a new AMRAAM missile production contract worth up to $20.7 billion and raised its full‑year adjusted EPS outlook to $7.10‑$7.25.

Expected impact

likely upward pressure as investors price in the large contract and guidance raise

Evidence & confidence

Large multi‑year defense award adds to backlog and improves earnings outlook, offsetting commercial‑aviation concerns.

Market effects

defense sector may see renewed buying interest on the back of the contract

U.S. defense stocks could benefit from perceived budget stability

global aerospace and defense investors may re‑price exposure to missile programs

Counterpoint

Commercial‑aviation weakness and engine cost issues could limit upside despite the contract

Key entities

  • RTX Corporation

    U.S. defense and aerospace contractor

Related articles

$RTXMed

$6.3 billion Pentagon deal buys more interceptors to shoot down ballistic missiles

Raytheon, an RTX business, received a $6.3 billion Pentagon contract for Standard Missile-3 Block IB interceptors. The deal includes $454 million in immediate funds for fiscal year 2026. Production will occur in Tucson, Arizona, and Huntsville, Alabama, supporting domestic defense vendors. The interceptors can be deployed from ship or land to defend against short- to intermediate-range ballistic missiles.

$RTXMed

RTX Initiates Coverage On Barclays -- Rating Set to Overweight

Barclays initiated coverage on RTX (Raytheon Technologies) with an 'Overweight' rating and a $223.00 price target. RTX is currently trading at $183.58, which is 18.2% overvalued according to its GF Value™ of $155.33. The company has a GF Score™ of 88/100, indicating strong overall performance. Insider activity shows significant selling, with $6.86 million in sales over the past three months.

$RTXHigh

Raytheon snaps up $6.3 billion deal for SM-3 IB interceptors

Raytheon, an RTX business, secured a $6.3B contract for SM-3 IB interceptors, spanning five years with two optional years. The deal supports missile defense inventory replenishment and is part of recent agreements with the Department of War. Production will occur at facilities in Tucson, Arizona, and Huntsville, Alabama. Raytheon's Phil Jasper highlighted the company's commitment to increasing munitions production.